We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eco Animal Health Group Plc | LSE:EAH | London | Ordinary Share | GB0032036807 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 102.50 | 100.00 | 105.00 | 102.50 | 102.50 | 102.50 | 16,478 | 07:36:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chem,fertlizer Minrl Mng,nec | 85.31M | 1.01M | 0.0149 | 68.79 | 69.44M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/6/2017 13:39 | Not only is "Malaysia ranked as a global top twenty egg producing country and home to four of the ten largest egg producers in Asia", but 'numerous' other approvals are expected in due course. So, excellent progress! Chart looks great - full of promise. | aimingupward2 | |
05/6/2017 08:24 | Indeed......very difficult to guestimate what each approval might add in terms of revenue/profit, but a 2% increase in the share price would appear modest! | tanners | |
05/6/2017 07:36 | More great news....the success story continues. | audigger | |
02/6/2017 12:20 | Edging up into new high ground at 600-610p. We could have £7 in prospect by the end of the month. | aimingupward2 | |
17/5/2017 11:30 | Yes, more approvals in the pipeline, that for countering swine respiratory disease in the U.S. being the key one. Re a possible bid, it's not in the hands of a bidder, much though it would be attractive to e.g. Ely Lilly or Merck or their subsidiaries. It'll be up to Peter Lawrence and the family holdings when and whether they want to let go. btw, when looking at the share price graph, I prefer to have a semi-log plot which you can do on the iii site. It's less startling and more reassuring. | aimingupward2 | |
17/5/2017 11:09 | So we have hit 600 on the offer; another milestone achieved. We must be due notification of some more approvals and hopefully a bid is not far away. There is major consolidation going on in the chemicals sector, especially in the Ag sector so its only a matter time before one of the bigger players comes in for Eco. | audigger | |
16/5/2017 19:44 | Indeed I do. Bought back in at 440 so am in profit, as are we all | audigger | |
16/5/2017 16:44 | Oh, that was unfortunate. Still, you have a direct holding, I believe, so at least that's had a leg up. Dividend up by 50% would replicate the increase at the interim, so 5p per share. Can't really see it being less than that. | aimingupward2 | |
16/5/2017 16:14 | Unfortunately I closed my spread bet.....needed the cash! It's all looking very good. I wonder how much they will increase the dividend? | audigger | |
15/5/2017 13:02 | Welcome back Au. Looks like you'll do very well with the spread bet. It's been a bit of a wait for news, but it's sounding really good given that 'expectations' would have been high anyway. It still looks like a good buy, ahead of what will clearly be excellent annual results at the end of June. It'll be interesting to see to what extent Shares Mag' and Investors Chronicle get behind this share and give it a further nudge later this week. | aimingupward2 | |
15/5/2017 12:23 | Only just logged on, nice to see we finally have an update. ITinvest, been a while since you posted here....all is looking good for PL's exit strategy to bring us handsome rewards. | audigger | |
15/5/2017 11:39 | Peel Hunt have raised their target price from 575p to 650p 😊 You can buy at the offer price of 565p but not inside that it seems. | aimingupward2 | |
15/5/2017 10:31 | LTH, just tried to have a small top up at the offered price , failed something is happening ? | winston8643 | |
15/5/2017 09:48 | Clear shift from Stage 1 to Stage 2 free stock charts from uk.advfn.com | luckymouse | |
15/5/2017 09:44 | Yes, it must be an attractive proposition for one of the majors in this field who have their own sales forces internationally and in whose hands the EAH business could achieve an EBITDA return of between 2 and 3 times greater than it does now largely using distributors. | aimingupward2 | |
15/5/2017 08:50 | I expect a bid for the company in the Not to distant future....LT | ltinvestor | |
15/5/2017 08:44 | congratulations fellas The announcement of the full results for the year to 31 March 2017 is anticipated to be released on 30 June 2017. | waldron | |
15/5/2017 08:43 | 5 now. I'm here and delighted by the news this morning. I expect AuDigger will join in soon. I really look forward to being able to read the full annual report. | aimingupward2 | |
15/5/2017 08:21 | Only 9 years for me. What's very encouraging, is that we only have patient sensible investors on this thread. Always a very encouraging sign. Only 4 of us here after that fantastic announcement. | topvest | |
15/5/2017 08:19 | Been waiting 17 years for this announcement!! | ltinvestor | |
15/5/2017 07:32 | indeed....and as revenue increases the relative increase in ptp is magnified which is a very healthy sign and indicative of a strong brand. | tanners | |
15/5/2017 07:01 | Short but yet perfectly sweet | hydrus | |
28/4/2017 20:25 | Yes, it certainly looks like a good wide platform to support a substantial rise once it starts. Perhaps it will take an rns to stimulate new buying interest, although there is already plenty of growth occuring, and to come, from licensing approvals already obtained over the last year. Probably the key approval expected this year is for treating swine respiratory disease in the U.S., although their are certainly a number of others in the pipeline. Otherwise, just a bit more patience until the results are out. I'm hoping for a near 60% increase in eps to close to 16p and a very positive outlook beyond that, so worth the wait. | aimingupward2 | |
28/4/2017 10:40 | Well all is quiet on the EAH front. share price stabilised at 500 as we head towards another record breaking set of figures. We haven't had a RNS for a while....can we have more product approvals please! | audigger |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions